rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    BNGO
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Bionano Genomics Inc (BNGO) (Q3 2026) Earnings Call Highlights: Record Flow Cell Sales and ...

      Bionano Genomics Inc (BNGO) posted 12% revenue growth to $8.3 million with record consumables and flow cell volumes, but software revenue fell 31% and supply constraints limited upside.

      Nov 11Yahoo FinanceBNGO
      Bionano Genomics, Inc. Q3 2026 Earnings Call Summary
      Nov 11Yahoo FinanceBNGO
      Bionano Genomics earnings missed by $0.03, revenue fell short of estimates
      Nov 11Investing.comBNGO
      Bionano Genomics Q3 2026 Earnings Call Transcript
      Nov 10BenzingaBNGO
      Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2026 Result
      Nov 9Yahoo FinanceBNGO
      Bionano Genomics Stock Surges Tuesday: What's Going On? - Bionano Genomics (NASDAQ:BNGO)

      Bionano Genomics is surging Tuesday as investors weigh its growth strategy and favorable milestones for its genome mapping technology.

      Sep 15BenzingaBNGO
      Bionano Genomics at H.C. Wainwright conference: push for clinical scale
      Sep 14Investing.comBNGO
      Bionano highlights studies showing OGM utility in blood cancers
      Sep 14Investing.comBNGO
      MolDX proposes Medicare coverage for Bionano genome mapping test
      Sep 10Investing.comBNGO
      Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms

      SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced that MolDX, a program that assesses molecular diagnostic technologies on behalf of Medicare Administrative Contractors (MACs), has issued a proposed Local Coverage Determination (LCD) for Genome-Wide Molecular Methodologies for the Detection of Copy Number Alterations and Structural Vari

      Sep 10Yahoo FinanceBNGO
      Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping
      Sep 8Yahoo FinanceBNGO
      Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

      SAN DIEGO, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that management will present and host 1x1 meetings at...

      Aug 24BarchartMCHUBNGO

      This is the newest page. Registered accounts read further back.